Heel medicines are available in 50 countries worldwide. Choose your country below to learn more.
Reckeweg Clinical Case Award 2016Heel granted this year’s Hans-Heinrich Reckeweg Clinical Case Award to Dr. Tina Decorte from Belgium. She received the Main Award for her case report on the treatment of an injured marathon runner. The Runner-up Award went to Dr. Liliana Consuegra Bazzani from Colombia for describing the therapy of a child with a rare skin disease. With the Award, Heel highlights the significance of practice-based evidence in medicine. More on the Hans-Heinrich Reckeweg Clinical Case Award
New trainees start at HeelOn Thursday, September 1, 14 young people started their training at the company’s headquarter in Baden-Baden. Heel offers pharmaceutical, chemical lab and technical apprenticeships, as well as in the area of business administration or IT and degree programs in various fields. Currently, 47 trainees work at Heel headquarters. More on the start of training at Heel
Press releaseHeel’s Traumeel® and Zeel® T shown to reduce pain of OA of the knee by more than 60% in MOZArT trial - Clinical data released at the 2015 European League Against Rheumatism (EULAR) congress show Traumeel® and Zeel® T co-administered intra-articular (IA) injections provide a new first line injection treatment option in the management of moderate to severe osteoarthritis of the knee, where oral pain management failed. More press releases